Rheumatoid arthritis: Pathogenic mechanisms and therapeutic targets

Rheumatoid arthritis: Pathogenic mechanisms and therapeutic targets

Numerous novel therapies are in development for rheumatoid arthritis as a consequence of tremendous progress in understanding pathogenic mechanisms and defining relevant disease cells and molecules. Anti-tumour necrosis factor alpha (TNFα) therapies have been particularly successful and set a new st...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Taylor, P, Feldmann, M
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2004

Míreanna comhchosúla

Molecular therapeutic targets in rheumatoid arthritis.
de réir: Sacre, S, et al.
Foilsithe / Cruthaithe: (2005)

TNF alpha as a therapeutic target in rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1994)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1995)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
de réir: Feldmann, M
Foilsithe / Cruthaithe: (1996)

TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2003)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2002)

Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: Preclinical and clinical studies
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2002)

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2008)

The Notch signaling-regulated angiogenesis in rheumatoid arthritis: pathogenic mechanisms and therapeutic potentials
de réir: Fang Zhao, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2002)

Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer
de réir: Maria Juarez, et al.
Foilsithe / Cruthaithe: (2012-02-01)

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
de réir: Jie Huang, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
de réir: Qi Jiang, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (1994)

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2003)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1994)

Rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1996)

Cytokine blockade in rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2001)

Rheumatoid arthritis: introduction.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1998)

Gene therapy for rheumatoid arthritis?
de réir: Feldmann, M
Foilsithe / Cruthaithe: (2001)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
de réir: Taylor, P, et al.
Foilsithe / Cruthaithe: (2009)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1997)

Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets
de réir: Jan Bilski, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
de réir: Thivya Balendran, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Immune, metabolism and therapeutic targets in RA (Rheumatoid Arthritis)
de réir: Liu Keying
Foilsithe / Cruthaithe: (2022-01-01)

Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.
de réir: Lin Wang, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis
de réir: Hongyan Qian, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Cytokine therapy in rheumatoid arthritis.
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (1996)

The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis
de réir: Brianne E. Barker, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets
de réir: Alessia Alunno, et al.
Foilsithe / Cruthaithe: (2017-11-01)

T-Follicular Regulatory Cells: Potential Therapeutic Targets in Rheumatoid Arthritis
de réir: Tingting Ding, et al.
Foilsithe / Cruthaithe: (2019-11-01)

Role of cytokines in rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1996)

Rheumatoid arthritis
de réir: Taylor, P
Foilsithe / Cruthaithe: (2022)

B Cells in Rheumatoid Arthritis：Pathogenic Mechanisms and Treatment Prospects
de réir: Fengping Wu, et al.
Foilsithe / Cruthaithe: (2021-09-01)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
de réir: Feldmann, M
Foilsithe / Cruthaithe: (1996)

Development of anti-TNF therapy for rheumatoid arthritis.
de réir: Feldmann, M
Foilsithe / Cruthaithe: (2002)

The role of cytokines in the pathogenesis of rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1999)

Treating-to-target or treating the patient in rheumatoid arthritis?
de réir: Taylor, PC, et al.
Foilsithe / Cruthaithe: (2019)

Therapeutic gene transfer for rheumatoid arthritis
de réir: M.C. Boissier, et al.
Foilsithe / Cruthaithe: (2011-09-01)

Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.
de réir: Full, L, et al.
Foilsithe / Cruthaithe: (2011)